October 17, 2024
TOPLINE: BARCELONA, Spain — Patients who receive a diagnosis of neovascular age-related macular degeneration (nAMD) from their primary care clinician may be less likely to adhere […]
October 16, 2024
BARCELONA, Spain — Ophthalmology has lagged far behind other specialties in adopting automated technology for the operating room, but a team of researchers in California has […]
October 4, 2024
The only approved ocular gene therapy, which targets a specific gene mutation in two forms of inherited retinal disease, has shown evidence in a real-world study […]
October 3, 2024
BARCELONA, Spain — Early findings from a real-world study of the dual-action antibody faricimab have shown sustained improvement in visual acuity and key biomarkers of retinal […]
October 3, 2024
TOPLINE: Faricimab demonstrated a greater reduction in hard exudates than aflibercept in patients with diabetic macular edema (DME), according to research presented at EURETINA 2024. Hard […]
October 2, 2024
TOPLINE: A 0.4 mg dose of aflibercept in infancy to treat retinopathy of prematurity (ROP) shows sustained efficacy and safety at 3 years of age, according […]
October 2, 2024
TOPLINE: Adjuvant chemotherapy after removal of the affected eye improves outcomes in children with unilateral retinoblastoma who have high-risk histopathologic features that predispose them to metastases […]
September 26, 2024
TOPLINE: Among patients with autoimmune hyperthyroidism, those who use cannabis are 1.9 times more likely to develop exophthalmos — eyes that appear to bulge from the […]
September 26, 2024
TOPLINE: Few federally qualified health centers (FQHCs) in Florida offer eye care services such as vision checks, prescriptions for glasses, and dilated eye exams, primarily provided […]